{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:15:35Z","timestamp":1784589335027,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T00:00:00Z","timestamp":1330992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10096-012-1577-y","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T18:03:02Z","timestamp":1330970582000},"page":"2359-2367","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic significance of serum antioxidant parameters in immunocompetent patients with cryptococcal meningitis"],"prefix":"10.1007","volume":"31","author":[{"given":"Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,6]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","volume":"80","author":"RD Diamond","year":"1974","unstructured":"Diamond RD, Bennett JE (1974) Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med 80:176\u2013181","journal-title":"Ann Intern Med"},{"key":"1577_CR2","first-page":"157","volume":"9","author":"BA Everett","year":"1978","unstructured":"Everett BA, Kusske JA, Rush JL, Pribram HW (1978) Cryptococcal infection of the central nervous system. Surg Neurol 9:157\u2013163","journal-title":"Surg Neurol"},{"key":"1577_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/jhin.1998.0610","volume":"42","author":"CH Lu","year":"1999","unstructured":"Lu CH, Chang WN, Chang HW, Chuang YC (1999) The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 42:313\u2013320","journal-title":"J Hosp Infect"},{"key":"1577_CR4","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/503570","volume":"42","author":"IZ Ecevit","year":"2006","unstructured":"Ecevit IZ, Clancy CJ, Schmalfuss IM, Nguyen MH (2006) The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis 42:1443\u20131447","journal-title":"Clin Infect Dis"},{"key":"1577_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/qjmed\/hcl014","volume":"99","author":"G Lui","year":"2006","unstructured":"Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, Chau S, Lai R, Cockram CS (2006) Cryptococcosis in apparently immunocompetent patients. QJM 99:143\u2013151","journal-title":"QJM"},{"key":"1577_CR6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","volume":"36","author":"SA Mirza","year":"2003","unstructured":"Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA (2003) The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000. Clin Infect Dis 36:789\u2013794","journal-title":"Clin Infect Dis"},{"key":"1577_CR7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3201\/eid1405.071312","volume":"14","author":"J Chen","year":"2008","unstructured":"Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ (2008) Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 14:755\u2013762","journal-title":"Emerg Infect Dis"},{"key":"1577_CR8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/13693780903437876","volume":"48","author":"LP Zhu","year":"2010","unstructured":"Zhu LP, Wu JQ, Xu B, Ou XT, Zhang QQ, Weng XH (2010) Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997\u20132007. Med Mycol 48:570\u2013579","journal-title":"Med Mycol"},{"key":"1577_CR9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000323390","volume":"36","author":"YY Chen","year":"2011","unstructured":"Chen YY, Lai CH (2011) Nationwide population-based epidemiologic study of cryptococcal meningitis in Taiwan. Neuroepidemiology 36:79\u201384","journal-title":"Neuroepidemiology"},{"key":"1577_CR10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinids\/17.5.837","volume":"17","author":"WG Powderly","year":"1993","unstructured":"Powderly WG (1993) Cryptococcal meningitis and AIDS. Clin Infect Dis 17:837\u2013842","journal-title":"Clin Infect Dis"},{"key":"1577_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0891-5520(05)70093-3","volume":"13","author":"SL Leib","year":"1999","unstructured":"Leib SL, T\u00e4uber MG (1999) Pathogenesis of bacterial meningitis. Infect Dis Clin North Am 13:527\u2013548","journal-title":"Infect Dis Clin North Am"},{"key":"1577_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1750-3639.1999.tb00211.x","volume":"9","author":"U Koedel","year":"1999","unstructured":"Koedel U, Pfister HW (1999) Oxidative stress in bacterial meningitis. Brain Pathol 9:57\u201367","journal-title":"Brain Pathol"},{"key":"1577_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pneurobio.2006.11.008","volume":"80","author":"M Klein","year":"2006","unstructured":"Klein M, Koedel U, Pfister HW (2006) Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? Prog Neurobiol 80:269\u2013280","journal-title":"Prog Neurobiol"},{"issue":"6 Suppl","key":"1577_CR14","doi-asserted-by":"crossref","first-page":"1129S","DOI":"10.1093\/ajcn\/54.6.1129s","volume":"54","author":"A Sevanian","year":"1991","unstructured":"Sevanian A, Davies KJ, Hochstein P (1991) Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54(6 Suppl):1129S\u20131134S","journal-title":"Am J Clin Nutr"},{"key":"1577_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s003940070030","volume":"39","author":"IF Benzie","year":"2000","unstructured":"Benzie IF (2000) Evolution of antioxidant defence mechanisms. Eur J Nutr 39:53\u201361","journal-title":"Eur J Nutr"},{"key":"1577_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277\u2013285","journal-title":"Clin Biochem"},{"key":"1577_CR17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043\u20131046","journal-title":"Science"},{"key":"1577_CR18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/mol.104.002832","volume":"66","author":"J Kapitulnik","year":"2004","unstructured":"Kapitulnik J (2004) Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 66:773\u2013779","journal-title":"Mol Pharmacol"},{"key":"1577_CR19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","volume":"317","author":"WE Dismukes","year":"1987","unstructured":"Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kaufman L, Soong S-J, Blackwelder WC (1987) Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 317:334\u2013341","journal-title":"N Engl J Med"},{"key":"1577_CR20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/377208","volume":"37","author":"PC Liliang","year":"2003","unstructured":"Liliang PC, Liang CL, Chang WN, Chen HJ, Su TM, Lu K, Lu CH (2003) Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. Clin Infect Dis 37:673\u2013678","journal-title":"Clin Infect Dis"},{"key":"1577_CR21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/432073","volume":"192","author":"AE Brouwer","year":"2005","unstructured":"Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, Day N, White NJ, Harrison TS (2005) Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis 192:681\u2013684","journal-title":"J Infect Dis"},{"key":"1577_CR22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/jinf.2001.0916","volume":"43","author":"P Pitisuttithum","year":"2001","unstructured":"Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ (2001) A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. J Infect 43:226\u2013233","journal-title":"J Infect"},{"key":"1577_CR23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","volume":"33","author":"PG Pappas","year":"2001","unstructured":"Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33:690\u2013699","journal-title":"Clin Infect Dis"},{"key":"1577_CR24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/qjmed\/93.4.245","volume":"93","author":"CC Shih","year":"2000","unstructured":"Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC (2000) Cryptococcal meningitis in non-HIV-infected patients. QJM 93:245\u2013251","journal-title":"QJM"},{"key":"1577_CR25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-2952(88)90126-8","volume":"37","author":"B Halliwell","year":"1988","unstructured":"Halliwell B (1988) Albumin\u2014an important extracellular antioxidant? Biochem Pharmacol 37:569\u2013571","journal-title":"Biochem Pharmacol"},{"key":"1577_CR26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1006\/jmcc.1999.1001","volume":"31","author":"JA Watts","year":"1999","unstructured":"Watts JA, Maiorano PC (1999) Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts. J Mol Cell Cardiol 31:1653\u20131662","journal-title":"J Mol Cell Cardiol"},{"key":"1577_CR27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pediatrneurol.2006.07.003","volume":"35","author":"A Aycicek","year":"2006","unstructured":"Aycicek A, Iscan A, Erel O, Akcali M, Selek S (2006) Total antioxidant\/oxidant status in meningism and meningitis. Pediatr Neurol 35:382\u2013386","journal-title":"Pediatr Neurol"},{"key":"1577_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pediatrneurol.2007.04.002","volume":"37","author":"A Aycicek","year":"2007","unstructured":"Aycicek A, Iscan A, Erel O, Akcali M, Ocak AR (2007) Oxidant and antioxidant parameters in the treatment of meningitis. Pediatr Neurol 37:117\u2013120","journal-title":"Pediatr Neurol"},{"key":"1577_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/rns.2011.028","volume":"22","author":"KD Prajapati","year":"2011","unstructured":"Prajapati KD, Sharma SS, Roy N (2011) Current perspectives on potential role of albumin in neuroprotection. Rev Neurosci 22:355\u2013363","journal-title":"Rev Neurosci"},{"key":"1577_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/515074","volume":"28","author":"PA Robinson","year":"1999","unstructured":"Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DA, Leedom JM, Larsen RA (1999) Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 28:82\u201392","journal-title":"Clin Infect Dis"},{"key":"1577_CR31","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1073\/pnas.96.5.2445","volume":"96","author":"S Dor\u00e9","year":"1999","unstructured":"Dor\u00e9 S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 96:2445\u20132450","journal-title":"Proc Natl Acad Sci USA"},{"key":"1577_CR32","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1073\/pnas.0813132106","volume":"106","author":"TW Sedlak","year":"2009","unstructured":"Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH (2009) Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 106:5171\u20135176","journal-title":"Proc Natl Acad Sci USA"},{"key":"1577_CR33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molmed.2005.04.008","volume":"11","author":"I Rigato","year":"2005","unstructured":"Rigato I, Ostrow JD, Tiribelli C (2005) Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med 11:277\u2013283","journal-title":"Trends Mol Med"},{"key":"1577_CR34","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1542\/peds.113.6.1776","volume":"113","author":"TW Sedlak","year":"2004","unstructured":"Sedlak TW, Snyder SH (2004) Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:1776\u20131782","journal-title":"Pediatrics"},{"key":"1577_CR35","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/S0024-3205(02)02137-9","volume":"71","author":"H Tsukahara","year":"2002","unstructured":"Tsukahara H, Haruta T, Todoroki Y, Hiraoka M, Noiri E, Maeda M, Mayumi M (2002) Oxidant and antioxidant activities in childhood meningitis. Life Sci 71:2797\u20132806","journal-title":"Life Sci"},{"key":"1577_CR36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clinbiochem.2011.03.137","volume":"44","author":"SS Huang","year":"2011","unstructured":"Huang SS, Huang PH, Chiang KH, Chen JW, Lin SJ (2011) Association of serum bilirubin levels with albuminuria in patients with essential hypertension. Clin Biochem 44:859\u2013863","journal-title":"Clin Biochem"},{"key":"1577_CR37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/abbi.2000.1721","volume":"376","author":"GL Squadrito","year":"2000","unstructured":"Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA (2000) Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376:333\u2013337","journal-title":"Arch Biochem Biophys"},{"key":"1577_CR38","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27:1174\u20131181","journal-title":"Eur Heart J"},{"key":"1577_CR39","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","volume":"85","author":"B Frei","year":"1988","unstructured":"Frei B, Stocker R, Ames BN (1988) Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85:9748\u20139752","journal-title":"Proc Natl Acad Sci USA"},{"key":"1577_CR40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/bj3030295","volume":"303","author":"A Vliet Van der","year":"1994","unstructured":"Van der Vliet A, Smith D, O\u2019Neill CA, Kaur H, Darley-Usmar V, Cross CE, Halliwell B (1994) Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 303:295\u2013301","journal-title":"Biochem J"},{"key":"1577_CR41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/clinids\/22.5.876","volume":"22","author":"AM Furth van","year":"1996","unstructured":"van Furth AM, Seijmonsbergen EM, Groeneveld PH, Van Furth R, Langermans JA (1996) Levels of nitric oxide correlate with high levels of tumor necrosis factor alpha in cerebrospinal fluid samples from children with bacterial meningitis. Clin Infect Dis 22:876\u2013878","journal-title":"Clin Infect Dis"},{"key":"1577_CR42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/315048","volume":"180","author":"S Kastenbauer","year":"1999","unstructured":"Kastenbauer S, Koedel U, Pfister H-W (1999) Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 180:1164\u20131170","journal-title":"J Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-012-1577-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-012-1577-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T20:09:48Z","timestamp":1561406988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-012-1577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,6]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s10096-012-1577-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,6]]}}}